Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

A second and larger group ran in the opposite direction, lower values signalled higher risk, and consisted almost entirely of markers of nutritional, hepatic, haematological and endocrine reserve: albumin and the albumin-to-globulin ratio, ALT and AST, triiodothyronine, haemoglobin and the other red-cell indices, total cholesterol and its fractions, vitamin D, folate and calcium.

Source: Univariate associations across the full panel. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Participants were grouped into tertiles of the linear predictor (log-rank test; high-versus-low tertile hazard ratio), and clinical utility was assessed by decision-curve analysis at three years against age-and-sex and the treat-all/treat-none strategies; the full model specification, enabling individual risk estimation, is provided as a coefficient equation (Supplementary Table S3) and an interactive calculator (Additional file 4).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Seven routine blood markers predict five-year mortality in older Indians: a risk score from the LASI-DAD cohort

Study design awaiting verification · Research Square · 2026

Original publication title

Seven routine blood markers predict five-year mortality in older Indians: a risk score from the LASI-DAD cohort

Bhrigu Jain; Sharmistha Dey; Aparajit Dey

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: Background.

Validated, blood-based tools to estimate short-to-medium-term mortality in older adults are derived almost entirely from European-ancestry or East Asian populations and transport poorly to South Asians, who present a distinct cardiometabolic and body-composition phenotype. No mortality risk score using routine blood markers exists for community-dwelling older Indians.

Source: Background.

Abstract: Methods.

We used Wave-1 data from the Longitudinal Aging Study in India: Diagnostic Assessment of Dementia (LASI-DAD), a nationally representative cohort of adults aged ≥ 60 years with venous biomarker phenotyping. Vital status was ascertained through an End-of-Life informant module to Wave 2. From the available venous panel, we pre-selected seven markers on biological grounds: N-terminal pro-B-type natriuretic peptide (NT-proBNP), serum albumin, cystatin C, high-sensitivity C-reactive protein (hs-CRP), the neutrophil-to-lymphocyte ratio (NLR), glycated haemoglobin (HbA1c) and alanine aminotransferase (ALT): and fitted a Cox proportional-hazards model with age and sex.

Discrimination (Harrell’s C), bootstrap optimism correction, calibration at three years, and risk-tertile stratification were assessed; decision-curve analysis quantified clinical utility.

Source: Methods.

Abstract: Results.

Among 2144 participants (540 deaths over a median 4.4 years of survivor follow-up; 25% mortality), the seven-marker score plus age and sex achieved an apparent C of 0.74 (optimism-corrected 0.74), versus 0.68 for age and sex alone (Δ ≈ 0.06); the blood panel alone reached C 0.72. NT-proBNP (hazard ratio [HR] per 1 SD 1.31), HbA1c (1.24) and albumin (0.81) carried most of the signal, with smaller contributions from cystatin C, ALT, NLR and hs-CRP. Calibration was excellent at three years.

Participants in the highest score tertile had 8.7-fold the mortality hazard of the lowest (95% CI 6.5 to 11.6; log-rank p < 0.001), with three-year mortality of 34% versus 6%. The score provided positive net benefit across clinically relevant decision thresholds. In sensitivity analyses, all associations persisted after adjustment for comorbidity, cognition and function, and the panel out-performed a clinical-plus-cognitive model.

Source: Results.

Abstract: Conclusions.

A seven-marker panel obtainable from a single venous sample, combined with age and sex, stratifies five-year mortality in older Indians with good discrimination and calibration. Pending external validation, it offers a clinically translatable, population-specific tool for prognostic risk stratification in a large and under-studied population.

Source: Conclusions.
Authors’ abstract

Background.

Validated, blood-based tools to estimate short-to-medium-term mortality in older adults are derived almost entirely from European-ancestry or East Asian populations and transport poorly to South Asians, who present a distinct cardiometabolic and body-composition phenotype. No mortality risk score using routine blood markers exists for community-dwelling older Indians.

Methods.

We used Wave-1 data from the Longitudinal Aging Study in India: Diagnostic Assessment of Dementia (LASI-DAD), a nationally representative cohort of adults aged ≥ 60 years with venous biomarker phenotyping. Vital status was ascertained through an End-of-Life informant module to Wave 2. From the available venous panel, we pre-selected seven markers on biological grounds: N-terminal pro-B-type natriuretic peptide (NT-proBNP), serum albumin, cystatin C, high-sensitivity C-reactive protein (hs-CRP), the neutrophil-to-lymphocyte ratio (NLR), glycated haemoglobin (HbA1c) and alanine aminotransferase (ALT): and fitted a Cox proportional-hazards model with age and sex.

Discrimination (Harrell’s C), bootstrap optimism correction, calibration at three years, and risk-tertile stratification were assessed; decision-curve analysis quantified clinical utility.

Results.

Among 2144 participants (540 deaths over a median 4.4 years of survivor follow-up; 25% mortality), the seven-marker score plus age and sex achieved an apparent C of 0.74 (optimism-corrected 0.74), versus 0.68 for age and sex alone (Δ ≈ 0.06); the blood panel alone reached C 0.72. NT-proBNP (hazard ratio [HR] per 1 SD 1.31), HbA1c (1.24) and albumin (0.81) carried most of the signal, with smaller contributions from cystatin C, ALT, NLR and hs-CRP. Calibration was excellent at three years.

Participants in the highest score tertile had 8.7-fold the mortality hazard of the lowest (95% CI 6.5 to 11.6; log-rank p < 0.001), with three-year mortality of 34% versus 6%. The score provided positive net benefit across clinically relevant decision thresholds. In sensitivity analyses, all associations persisted after adjustment for comorbidity, cognition and function, and the panel out-performed a clinical-plus-cognitive model.

Conclusions.

A seven-marker panel obtainable from a single venous sample, combined with age and sex, stratifies five-year mortality in older Indians with good discrimination and calibration. Pending external validation, it offers a clinically translatable, population-specific tool for prognostic risk stratification in a large and under-studied population.

Trial registration:

Not applicable (observational cohort analysis).

Publication and source details

Original title: Seven routine blood markers predict five-year mortality in older Indians: a risk score from the LASI-DAD cohort

Bhrigu Jain; Sharmistha Dey; Aparajit Dey

Research Square · 2026

Author Contribution

Study concept and design: B.J. Acquisition of subjects and data: S.D., A.D. Analysis and interpretation of data: B.J., A.D. Preparation of manuscript: B.J., S.D., A.D. drafted the manuscript; all authors critically revised it for important intellectual content and approved the final version. The corresponding author affirms that all those who contributed significantly are listed as authors.

sharmistha_d@hotmail.com
https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License, which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T21:50:36.926710+00:00

DOI: 10.21203/rs.3.rs-9979288/v1 · PMC13370638